Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations

Human Mutation

Volumn 8, Issue 1, 1996, Pages 64-70

  Kambouris, Marios ^a   Jackson, Charles E ^a   Feldman, Gerald L ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Heteroduplex analyses; Multiple endocrine neoplasia; Mutation detection enhancement; RET proto oncogene

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; DNA DETERMINATION; FAMILIAL CANCER; GENE AMPLIFICATION; GENE MUTATION; HUMAN; NEUROFIBROMATOSIS; ONCOGENE RET; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

CARCINOMA, MEDULLARY; DROSOPHILA PROTEINS; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; MUTATION; NUCLEIC ACID HETERODUPLEXES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0029896244     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1996)8:1<64::AID-HUMU9>3.0.CO;2-P     Document Type: Article

References (35)

1. Bhattacharya A, Lilley DM (1989) The contrasting structures of mismatched DNA sequences containing looped-out bases (bulges) and multiple mismatches (bubbles). Nucleic Acid Res 17:6821-6840.
2. Blaugrund JE, Johns MM, Eby YJ, Ball DW, Baylin SB, Hruban RH, Sidransky D (1994) RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum Mol Genet 3:1895-1897.
3. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SAJr, Goodfellow PJ, Donis-Keller H (1994) A single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579-1583.
4. Carney JA, Sizemore GW, Lovestedt SA (1976) Mucosal ganglioneuromatosis, medullary thyroid cancer, and pheochromocytoma: Multiple endocrine neoplasia, type 2b. Oral Surg Oral Med Oral Path 41:739-752.
5. Ceccherini I, Hofstra RMW, Luo Y, Stulp RP, Barone V, Stelwagen T, Bocciardi R, Nijveen H, Bolino A, Seri M, Ronchetto ' P, Pasini B, Bozzano M, Buys CHCM, Romeo G (1994) DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto-oncogene. Oncogene 9:3025-3029.
6. Cotton RG, Malcolm AD (1991) Mutation detection. Nature 353:582-583.
7. Decker RA, Peacock ML, Borst MJ, Sweet JD, Thompson NW (1995) Progress in genetic screening of multiple endocrine neoplasia type 2A: Is calcitonin testing absolete? Surgery 118:257-264.
8. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SAJr (1993) Mutations in the RET proto-oncogene are associated with MEN 2 A and FMTC. Hum Mol Genet 2:851-856.
9. Easton DF, Ponder MA, Cummings T, Gagel RF, Hansen HH, Reichlin S, Tashjian AH, Telenious-Berg M, Ponder BAJ, Cancer Research Campaign Medullary Thyroid Group (1989) The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet 44:208-215.
10. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fekete C, Ponder BAJ, Munnich A (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378-380.
11. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson CE, Tunnacliffe A, Ponder BAJ (1994) Point mutations within tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia Type 2B, and related sporadic tumors. Hum Mol Genet 3:237-241.
12. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HPH, Pfragner R, Behmel A, Lorenzo MJ, Stone-house TJ, Ponder MA, Ponder BAJ (1995a) Mutations of the RET proto-oncogene in sporadic medullary thyroid cancer. Genes Chrom Cancer 12:209-212.
13. Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stone-house TJ, Ponder MA, Jackson CE, Waterfield M, Ponder BAJ (1995b) A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10:509-513.
14. Farndon JR, Leight GS, Dilley WG, Baylin SB, Smallridge RC, Harrison TS, Wells SAJr (1986) Familial medullary thyroid cancer without associated endocrinopathies: A distinct clinical entity. Br J Surg 73:278-281.
15. Feldman GL, Kambouris M, Talpos GB, Mulligan LM, Ponder BAJ, Jackson CE (1994) Clinical value of direct DNA analysis of the RET proto-oncogene in families with Multiple Endocrine Neoplasia type 2A. Surgery 116:1042-1047.
16. Gagel RF, Tashjian AHJr, Cummings T, Papathanasopoulos N, Kaplan MM, DeLellis RA, Wojfe HJ, Reichlin S (1988) The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a: An 18-year experience. N Engl J Med 318:478-484.
17. Gardner E, Papi L, Easton DF, Cummings T, Jackson CE, Kaplan M, Love DR, Mole SE, Moore JK, Mulligan L M, Norum RA, Ponder MA, Reichlin S, Stall G, Telenius H, Telenius-Berg M, Tunnacliffe A, Ponder BAJ (1993) Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2. Hum Mol Genet 2:241-246.
18. Hennessy JF, Wells SAJr, Ontjes DA, Cooper CW (1974) A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary cancer of the thyroid. J Clin Endocrinol Metab 39:487-495.
19. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JWM, PIoos van Amstel HK, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid cancer. Nature 367:375-376.
20. Jackson CE, Norum RA (1989) Genetic mechanisms of neoplasia in MEN 2. Henry Ford Hosp Med J 37:116-119.
21. Keen J, Lester D, Inglehearn C, Omis A, Bhattacharya S (1991) Rapid detection of single base mismatches as heteroduplexes on HydroLink gels. Trends Genet 7:5.
22. Lairmore TC, Howe JR, Korte JA, Dilley WG, Aine L, Aine E, Wells SAJr, Donis-Keller H (1991) Familial medullary thyroid cancer and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type ZA. Genomics 9:181-192 [Erratum, Genomics 1991 10:514].
23. Lips JMC, Landsvater RM, Hoppener JWM, Geerding RA, Blijham G, Jansen-Schillhorn van Veen JM, van Gils APG, de Will MJ, Zewald RA, Berends MJH, Beemer FA, BrouwersSmalbraak J, Jansen RPM, van Amstel HKP, van Vroonhoven TJMV, Vroom TM (1994) Clinical screening as compared with DNA analysis in families with Multiple Endocrine Neoplasia type 2A. N Engl J Med 331:828-835.
24. Mathew CGP, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI Fong SL, Bridges CDB, Haak H, Nieuwenhuijzen Kruseman AC, Schifter S, Hansen HH, Telenius H, Telenius-Berg M, Ponder BAJ (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328:527-528.
25. Melvin KEW, Miller HH, Tashjian AHJr (1971) Early diagnosis of medullary cancer of the thyroid gland by means of calcitonin assay. N Engl J Med 285:1115-1120.
26. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JBJ, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Thibodeau SN, Ponder BAJ. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet 6:70-74.
27. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.
28. Ponder BAJ, Coffey R, Gagel RF, Semple P, Ponder MA, Pembrey ME, Telenius-Burg M, Easton DF, Cancer Research Campaign Medullary Thyroid Group (1988) Risk estimation and screen-ing in families of patients with medullary thyroid carcinoma. Lancet 8582:397-401.
29. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kaariainen H, Martucciello G (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377-378.
30. Sambrook J, Fritsch EF, Maniatis T (1989) In: Nolan C (ed): Molecular cloning: A Laboratory Manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
31. Schimke RN, Hartmann WH, Prout TE, Rimoin DL (1968) Syndrome of bilateral pheochromocytoma, medullary thyroid cancer and multiple neuromas: A possible regulatory defect in the differentiation of chromaffin tissue. N Engl J Med 279:1-7.
32. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir CM, GETC (1994) RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 3:1939-1943.
33. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JR, Jackson CE, Duncan AMV, Farrer LA, Brasch K, Castiglione C, Genel M, Gertner J, Greenberg CR, Gusella JF, Holden JJA, White BN (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328:528-530.
34. Sipple JH (1961) The association of pheochromocytoma with cancer of the thyroid gland. Am J Med 31:163-166.
35. Steiner AL, Goodman AD, Powers SRJr (1968) Study of a kindred with pheochromocytoma, medullary thyroid cancer, hyperparathyroidism and Cushing's disease: Multiple endocrine neoplasia, type 2. Medicine 47:371-409.